Literature DB >> 31182556

Post-PIVOTAL Iron Dosing with Maintenance Hemodialysis.

David Collister1,2, Navdeep Tangri3,4.   

Abstract

Entities:  

Keywords:  Kidney Failure, Chronic; anemia; dialysis; erythropoietin; iron

Mesh：

Substances：

Year:  2019        PMID： 31182556      PMCID： PMC6777601          DOI： 10.2215/CJN.02300219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  8 in total

1.  Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Iain C Macdougall; Andreas J Bircher; Kai-Uwe Eckardt; Gregorio T Obrador; Carol A Pollock; Peter Stenvinkel; Dorine W Swinkels; Christoph Wanner; Günter Weiss; Glenn M Chertow
Journal:  Kidney Int       Date:  2016-01       Impact factor: 10.612

2.  Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis.

Authors:  Ingrid Hougen; David Collister; Mathieu Bourrier; Thomas Ferguson; Laura Hochheim; Paul Komenda; Claudio Rigatto; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-20       Impact factor: 8.237

3.  Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.

Authors:  Daniel W Coyne; Toros Kapoian; Wadi Suki; Ajay K Singh; John E Moran; Naomi V Dahl; Adel R Rizkala
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

4.  Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?

Authors:  Simona Stancu; Liliana Bârsan; Ana Stanciu; Gabriel Mircescu
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

5.  Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.

Authors:  Toros Kapoian; Neeta B O'Mara; Ajay K Singh; John Moran; Adel R Rizkala; Robert Geronemus; Robert C Kopelman; Naomi V Dahl; Daniel W Coyne
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

6.  Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.

Authors:  Iain C Macdougall; Claire White; Stefan D Anker; Sunil Bhandari; Kenneth Farrington; Philip A Kalra; John J V McMurray; Heather Murray; Charles R V Tomson; David C Wheeler; Christopher G Winearls; Ian Ford
Journal:  N Engl J Med       Date:  2018-10-26       Impact factor: 91.245

7.  Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.

Authors:  M Alan Brookhart; Janet K Freburger; Alan R Ellis; Lily Wang; Wolfgang C Winkelmayer; Abhijit V Kshirsagar
Journal:  J Am Soc Nephrol       Date:  2013-06-20       Impact factor: 10.121

8.  Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.

Authors:  Guy Rostoker; Mireille Griuncelli; Christelle Loridon; Théophile Magna; Gabrielle Machado; Gilles Drahi; Hervé Dahan; Philippe Janklewicz; Yves Cohen
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240
  8 in total
  2 in total

1.  Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: COMMENTARY.

Authors:  Frank Liu
Journal:  Kidney360       Date:  2021-08-06

2.  Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis Patients.

Authors:  Angelo Karaboyas; Hal Morgenstern; Nancy L Fleischer; Douglas E Schaubel; Bruce M Robinson
Journal:  Clin Epidemiol       Date:  2020-11-11       Impact factor: 4.790
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.